Experience

Davis Polk advised the underwriters in the initial public offering of Ocumension Therapeutics on the Hong Kong Stock Exchange and an international offering and listing in reliance on Rule…

Davis Polk advised Outotec Oyj as to U.S. law in connection with the demerger by Metso Corporation’s minerals business by way of transfer (without liquidation of Metso) to Outotec and…

Davis Polk advised Shenzhen Hepalink Pharmaceutical Group Co., Ltd. in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering…

Davis Polk advised Sumitomo Mitsui Financial Group, Inc. on its SEC-registered takedown offering of senior total loss-absorbing capacity (“TLAC”) notes, which consisted of $1.5 billion…

Davis Polk is advising Ucommune Group Holdings Ltd. on its merger with Orisun Acquisition Corp. The transaction values the new group at approximately $769 million at closing and will…

Davis Polk advised the joint lead managers in connection with the Rule 144A/Regulation S offering by the Hashemite Kingdom of Jordan of $500 million aggregate principal amount of its 4.950%…

 Davis Polk advised the joint book-running managers in connection with concurrent SEC-registered offerings by II-VI Incorporated of 10,697,570 shares of its common stock for an…

Davis Polk advised Raízen Fuels Finance S.A., as issuer and Raízen Combustiveis S.A. and Raízen Energia S.A., as guarantors, in connection with Raízen Fuels’ $225 million reopening of its 5…

Davis Polk advised XP Inc. in connection with an SEC-registered secondary offering of 22,465,733 Class A common shares by certain selling shareholders at a price per Class A common share of…

Davis Polk advised an ad hoc group (the “Ad Hoc Group”) of prepetition secured term lenders and DIP term lenders in connection with the chapter 11 cases of McDermott International, Inc. and…